Mitochondrial disease
Gene: PTRH2
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease-1 (IMNEPD1) is an autosomal recessive multisystemic disorder with variable expressivity. The core features usually include global developmental delay with impaired intellectual development and speech delay, ataxia, sensorineural hearing loss, and pancreatic insufficiency. Additional features may include peripheral neuropathy, postnatal microcephaly, dysmorphic facial features, and cerebellar atrophy.
More than 5 unrelated families reported. The Q85P missense variant is reported in several families, likely founder effect.
Protein is involved in mitochondrial translation.Created: 14 Apr 2022, 8:26 p.m. | Last Modified: 5 Dec 2025, 1:07 p.m.
Panel Version: 0.1121
Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal
Phenotypes
Infantile-onset multisystem neurologic, endocrine, and pancreatic disease, MIM# 616263
Publications
Gene: ptrh2 has been classified as Green List (High Evidence).
Publications for gene: PTRH2 were set to 29884839; 37239392
gene: PTRH2 was added gene: PTRH2 was added to Mitochondrial disease. Sources: Expert Review Green Mode of inheritance for gene: PTRH2 was set to BIALLELIC, autosomal or pseudoautosomal Publications for gene: PTRH2 were set to 29884839; 37239392 Phenotypes for gene: PTRH2 were set to Miscellaneous disorders associated with mitochondrial dysfunction; neurologic, endocrine, and pancreatic disease, multisystem, infantile-onset 1 MONDO:8000012